Highlights from the China Interchange
Director, Events and Japan Initiatives, CDISC
Attendees expressed that this was our best China conference yet, and that this year had a certain energy that was felt by everyone. Many attendees remarked that the content of the program was robust and refreshing. Our exhibitor area was also humming with activity across the two Main Conference days, and most of our sponsors mentioned that they planned to exhibit next year. CDISC would like to give special thanks to our Diamond Sponsor, Beijing Improve-Quality Tech Co., Ltd., as well as our many other sponsors for their invaluable support of this event. We would also like to give our deepest gratitude to the members of the CDISC China Coordinating Committee (C3C), without whom this conference would not be possible. We are tremendously grateful for your continued support of CDISC in China.
The 2019 CDISC China Interchange was held in Beijing 19 – 20 September. This year’s conference saw the highest attendance numbers for its Main Conference yet, with 200 total attendees across both the conference and education courses. The two-track conference at times was filled to overflowing, and attendees gained insights on hot topics like Real World Data, AI, CDISC 360 and CDISC Library, End-to-End Automation, eSubmission and more.
The Keynote presentation, “The Evolving Drug Development Ecosystem in China” was provided by Dr. Zhengqing Li, Vice President and General Manager of MSD China R&D and CDISC Board member. Speakers from the FDA and PMDA provided presentations on data standards, nonclinical study data and SEND, safety review, eSubmission and requirements.